Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV Cohort Study

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue 5, 2006, Pages 550-555

  Keiser, Olivia ^a   Tejada, Begoña Martinez De ^b   Wunder, Dorothea ^c   Chapuis Taillard, Caroline ^d   Zellweger, Claudine ^c,i   Zinkernagel, Annelies S ^e,j   Elzi, Luigia ^f   Schmid, Patrick ^g   Bernasconi, Enos ^h   Aebi Popp, Karoline ^f   Rickenbach, Martin ^a,d   Battegay, M ^m   Bernasconi, E ^m   Boni J ^m   Bucher, H ^m   Burgisser Ph ^m   Cattacin, S ^m   Cavassini, M ^m   Dubs, R ^m   Egger, M ^m   Elzi, L ^m   Erb, P ^m   Fischer, M ^m   Flepp, M ^m   Fontana, A ^m   Francioli, P ^d   Furrer, H ^k   Gorgievski, M ^m   Gunthard H ^m   Hirschel, B ^m   Hosli I ^m   Kahlert, Ch ^m   Kaiser, L ^m   Karrer, U ^m   Keiser, O ^m   Kind, C ^m   Klimkait, Th ^m   Ledergerber, B ^m   Martinez, B ^m   Muller N ^m   Nadal, D ^m   Opravil, M ^m   Paccaud, F ^m   Pantaleo, G ^m   Perrin, L ^m   Piffaretti, J C ^m   Rickenbach, M ^l   Rudin, C ^m   Schmid, P ^m   Schultze, D ^m   Schupbach J ^m   Speck, R ^m   Taffe P ^m   Tarr, P ^m   Telenti, A ^m   Trkola, A ^m   Vernazza, P ^m   Weber, R ^m   Yerly, S ^m   more..

^a Data Center of the Swiss HIV Cohort Study   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^h REGIONAL HOSPITAL OF LUGANO   (Switzerland)

ⁱ Department of Medicine   (Switzerland)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k Clinical and Laboratory Committee

^l Data Center   (Switzerland)

^m Clinical and Laboratory Committee ^*

more..

Author keywords

Cervical dysplasia; Gynecology; HIV; Papanicolaou smear; Women

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; ETHNOLOGY; FEMALE; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; OBESITY; PRIORITY JOURNAL; QUESTIONNAIRE; SEROLOGY; SEXUAL BEHAVIOR; SMOKING; SWITZERLAND; SYPHILIS; UNDERWEIGHT; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS LOAD;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; PRACTICE GUIDELINES; SWITZERLAND; UTERINE CERVICAL NEOPLASMS;

EID: 33845351106     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000245884.66509.7a     Document Type: Article

References (27)

1. Korn AP. Gynecologic care of women infected with HIV. Clin Obstet Gynecol. 2001;44:226-242.
2. Williams AB. Gynecologic care for women with HIV infection. J Obstet Gynecol Neonatal Nurs. 2003;32:87-93.
3. Maiman M, Fruchter RG, Serur E, et al. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol. 1993;82:170-174.
4. Fruchter RG, Maiman M, Sedlis A, et al. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol. 1996;87:338-344.
5. Northfelt DW. Cervical and anal neoplasia and HPV infection in persons with HIV infection. Oncology (Huntingt). 1994;8:33-37.
6. Hankins CA, Lamont JA, Handley MA. Cervicovaginal screening in women with HIV infection: a need for increased vigilance? CMAJ. 1994;150:681-686.
7. Guideline zum Vorgehen bei suspektem und positiven zytologischen Abstrich der Cervix Uteri. Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe AGZS. 2004. Available at: http://www.sggg.ch/D/guidelines/pdf/ vorgehen_d.pdf.
8. USPHS/IDSA Prevention of Opportunistic Infections Working Group. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Recomm Rep. 1997;46:1-46.
9. Diggle PJ, Heagerty P, Liang KY, et al. Analysis of Longitudinal Data. Oxford University Press, Oxford, UK; 2002.
10. Stein MD, Cunningham WE, Nakazono T, et al. Screening for cervical cancer in HIV-infected women receiving care in the United States. J Acquir Immune Defic Syndr. 2001;27:463-466.
11. Solomon L, Stein M, Flynn C, et al. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:253-261.
12. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425-432.
13. Østbye T, Taylor DH, Yancy WS, et al. Associations between obesity and receipt of screening mammography, Papanicolaou tests, and influenza vaccination: results from the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) Study. Am J Public Health. 2005;95:1623-1630.
14. Adams CH, Smith NJ,Wilbur DC, et al. The relationship of obesity to the frequency of pelvic examinations: do physician and patient attitudes make a difference? Women Health. 1993;20:45-57.
15. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625-1638.
16. Bosch FX, Munoz N, de SS, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer. 1992;52:750-758.
17. Tang AM, Forrester J, Spiegelman D, et al. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:230-236.
18. Wanke C. Pathogenesis and consequences of HIV-associated wasting. J Acquir Immune Defic Syndr. 2004;37(Suppl 5):S277-S279.
19. Serraino D, Pavia C, Navarra A, et al. Knowledge and use of Papanicolaou test among HIV-positive women. Int J Cancer. 2005;115:1009-1010.
20. Piette JD, Mor V, Mayer K, et al. The effects of immune status and race on health service use among people with HIV disease. Am J Public Health. 1993;83:510-514.
21. Moore RD, Stanton D, Gopalan R, et al. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med. 1994;330:763-768.
22. Staehelin C, Rickenbach M, Low N, et al. Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival. AIDS. 2003;17:2237-2244.
23. Abercrombie PD. Improving adherence to abnormal Pap smear follow-up. J Obstet Gynecol Neonatal Nurs. 2001;30:80-88.
24. Bowman JA, Sanson-Fisher R, Redman S. The accuracy of self-reported Pap smear utilisation. Soc Sci Med. 1997;44:969-976.
25. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993;85:566-570.
26. Pizarro J, Schneider TR, Salovey P. A source of error in self-reports of Pap test utilization. J Community Health. 2002;27:351-356.
27. Ledergerber B, von Overbeck J, Egger M, et al. The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Soz Praventivmed. 1994;39:387-394.